Controversy and Progress in Alzheimers Disease - FDA Approval of AducanumabNEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021
OKT3 EncephalopathyAnn Neurol 28:837-838, Coleman,A.E.&Norman,D.J., 1990